View Older Stories

Jul 27, 2026 10:12AM Oppenheimer Reiterates Capricor Therapeutics (CAPR) at Outperform, 'like the risk-reward'

Jul 27, 2026 07:55AM Capricor Therapeutics (CAPR) Falls 26% Following FDA Briefing Docs Post

Jul 15, 2026 07:48AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald

Jul 7, 2026 07:18AM Capricor Therapeutics (CAPR) Reiterates Overweight Rating Ahead of Upcoming PDUFA

Jun 29, 2026 05:58AM Capricor Therapeutics (CAPR) 4500 contracts of August 30 calls and 2900 contracts of August 20 puts trade

May 13, 2026 04:15AM B.Riley Reiterates Buy Rating on Capricor Therapeutics (CAPR)

May 12, 2026 04:13PM Capricor Therapeutics (CAPR) Misses Q1 EPS by 7c

May 8, 2026 07:15AM Capricor sues NS Pharma over Duchenne therapy distribution deal

Mar 13, 2026 07:30AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald After Q4 Result

Mar 12, 2026 04:17PM Capricor Therapeutics (CAPR) Misses Q4 EPS by 11c

Mar 12, 2026 09:02AM Capricor reports positive HOPE-3 trial results for Duchenne therapy

Mar 10, 2026 10:37AM Jones Trading Reiterates Buy Rating on Capricor Therapeutics (CAPR) as FDA review resumed

Mar 10, 2026 10:05AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)

Mar 10, 2026 09:25AM FDA sets new PDUFA date for Capricor's Deramiocel therapy

Mar 9, 2026 07:46AM Truist on Head of CBER at FDA Exit: 'we anticipate a positive stock reaction for IRON CAPT RGNX QURE'

Jan 29, 2026 06:21AM Oppenheimer Reiterates Outperform Rating on Capricor Therapeutics (CAPR)

Jan 20, 2026 09:15AM CAPR receives FDA request for clinical study report on Deramiocel

Jan 16, 2026 07:11AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald

Jan 14, 2026 06:57AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 17, 2025 06:59AM Piper Sandler: 'We Are Naming Capricor Therapeutics (CAPR) As a 2026 Top Pick'

Dec 10, 2025 07:42AM Capricor Therapeutics (CAPR) PT Raised to $45 at Piper Sandler

Dec 8, 2025 07:09AM Capricor Therapeutics (CAPR) PT Raised to $54 at Oppenheimer

Dec 4, 2025 05:48AM Capricor Therapeutics (CAPR) call put ratio 1 call to 1.6 puts as share price up

Dec 3, 2025 02:59PM Capricor Therapeutics (CAPR) PT Raised to $51 at Jones Trading

Dec 3, 2025 01:38PM Capricor Therapeutics (CAPR) PT Raised to $60 at H.C. Wainwright

Dec 3, 2025 10:00AM B.Riley Reiterates Capricor (CAPR) at Buy, 'believe Deramiocel peak sales could likely exceed $1B'

Dec 3, 2025 07:15AM Capricor Therapeutics (CAPR) Halted, News Pending

Dec 2, 2025 05:34AM Increasing unusual put option volume: CAPR ABTC BRR WY HUBS PALL SM IOT

Nov 25, 2025 04:41AM Increasing unusual put option volume: EWC DJX SLG CAPR STNG HUBS ANF URBN DLO WGS KVYO

Nov 24, 2025 01:24PM Increasing unusual put option volume: SLG CAPR DLO WGS TSCO

Nov 24, 2025 10:04AM Capricor Therapeutics (CAPR) Mentioned as Short by Shkreli

Nov 24, 2025 09:01AM Capricor presents scalable exosome loading framework at AAEV conference

Nov 13, 2025 10:50AM Capricor Therapeutics (CAPR) call put ratio 1 call to 5.6 puts with a focus on November 2.5 puts

Nov 10, 2025 04:04PM Capricor Therapeutics (CAPR) Reports In-Line Q3 EPS, offers outlook

Nov 3, 2025 09:15AM Capricor Therapeutics publishes study on Deramiocel mechanism

Sep 25, 2025 10:44AM Options with decreasing option implied volatility: CAPR FDX WBD ACN MU LEN

Sep 25, 2025 07:15AM Capricor receives FDA clarity on Deramiocel approval path for DMD

Sep 18, 2025 05:08AM Jones Trading Reiterates Buy Rating on Capricor Therapeutics (CAPR)

Sep 12, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)

Sep 9, 2025 09:23AM Capricor responds to FDA posting of Deramiocel rejection letter

Aug 19, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)

Aug 11, 2025 04:35PM Capricor Therapeutics (CAPR) Misses Q2 EPS by 9c

Aug 8, 2025 08:30AM Capricor schedules FDA meeting on Deramiocel regulatory path

Jul 22, 2025 06:44AM Oppenheimer Reiterates Outperform Rating on Capricor Therapeutics (CAPR)

Jul 20, 2025 04:00PM CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jul 20, 2025 10:52AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics

Jul 18, 2025 01:43PM CAPR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc. Investors

Jul 14, 2025 06:58AM Capricor Therapeutics (CAPR) PT Lowered to $24 at H.C. Wainwright

View Older Stories